Experts believe gene therapies will disrupt Gaucher disease drug market: GlobalData
Gaucher disease, a rare inherited metabolic disorder caused by defects in the GBA1 gene, results in harmful glucocerebroside…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Gaucher disease
Sanofi receives SEC recommendation to bring new therapies of Pompe, ASMD to India
The company hopes to launch these therapies in India by end of 2023 or beginning of next year, subject to completion of all…